The Beijing Changrui Foundation is a philanthropic organization that focuses on educational and medical services to support underprivileged communities. It engages in activities such as organizing STEM educational events, donating technology corners to schools, and encouraging students to explore science and technology through hands-on learning experiences.

CPE is an alternative asset manager with extensive China experience and, at the same time, an international perspective. With a long-term vision and value investment strategy, CPE provides innovative investment solutions to leading firms from the following four key sectors - healthcare, consumer and internet, technology and industrial, software and enterprise services. Currently with its successful long-term performance, CPE's funds under management are supported by over 200 domestic and international institutional investors across North America, Europe, Asia and the Middle East. The core investment team has completed more than 200 investments globally and has an outstanding track record in multiple USD and RMB funds with a total AUM exceeding RMB100 billion, enabling the firm to accumulate key sector knowledge and a widespread business network. With a solid investment and research process, strong sector expertise and professional portfolio management capabilities, CPE builds long-term relationships with its portfolios in order to drive their value creation and sustainable growth.

Happigo

JD Health

JW Therapeutics

guanaitong.com

Hesai Technology

Touch

Shanghai ANE Logistics

17zuoye

3D Medicines

Best

Weilong Foods

Zhongce Che Kongjian

Biocytogen

Cheyipai

ELEME

Fenbi

CStone Pharmaceuticals

CPE-backed Beauty Farm, a Chinese beauty salon chain, (Stock Code: 2373.HK) has been breaking new highs repeatedly with its share price and turnover rate since the company went public. Beauty Farm completed the issuance of its shares on January 16, 2023. Three days after the listing, the company has seen continuous surge in share price and record-breaking turnover rate. As of January 18, 2023, the stock price of Beauty Farm was HK$27.05, with a total market capitalization of over HK$6 billion. 
 
CPE made a buyout investment in Beauty Farm in 2013. Within the past ten years, CPE's investment team and portfolio management team have been closely involved in various aspects of Beauty Farm's business, including governance, strategic transformation, senior talent recruitment, M&A and expansion, branding and design improvement, human resources optimization, supply chain innovation, omni-channel marketing, public relations and financial management. CPE's long-term holding of Beauty Farm for ten years has now generated "satisfactory" returns.

Recently, Chinese Venture released its "China Bridge 2022 China's Equity Investments List". CPE was awarded with "2022 China's Top10 Private Equity Investment Institutions" and "2022 China's Best Return Private Equity Investment Institutions". Meanwhile, CPE's investment in OPM was awarded with "2022 China's Best Exit Case". Chinese Venture conducted a comprehensive research and data analysis on each investment institution's perfomance in 2022, including insistution's asset under management, fundraising capability, investment capability, valuation of investment portfolio, investment refinancing, exit, etc.

Recently, over 10 portfolio companies of CPE have been listed in the 2022 Venture 50 list launched by Zero2IPO and PE Daily. Venture 50 was founded by Zero2IPO in 2006 and has been continuously developing since then, aiming to discover unlisted industry-leading companies. The list has become a benchmark for high-growth companies' investments for its expertise and in-depth industry analysis. As of October 2022, Venture 50 has a cumulative total of over 70,000 entries, with a listing rate of 27.8% within the past three years.

MIT Technology Review recently released its 2021 list of the "50 Smartest Companies" (TR50). Six of CPE's portfolio companies made it to the list included BYD Semiconductor, Abiochem, MicroPort MedBot, Biocytogen, Incilico Medicine and Innorna. These companies were recognized for their outstanding technological innovation capabilities, successful business models and robust sustainability solutions in their respective fields.
 
Founded in 1899, MIT Technology Review is a world-renewed technology media publication that focuses on the emerging technologies and innovative businesses of each era. Since 2010, the publication has been publishing an annual list of the "50 Smartest Companies", gaining insights into the megatrends influencing the future of technology.

On May 30th, China Venture Info published its 16th ranking of China's venture capital and private equity companies. CPE was recognized in 10 categories, including in 'China's Top Three Private Equity Investment Institutions', 'China's Top Private Equity Investment Institution' and 'China's Top Five Private Equity Investment Institutions by Returns'.
 
Additionally, several of CPE's portfolio companies won awards in the 'Top Investment Cases' category in recognition of their standing in various industries, including Biotheus, Insilico Medicine, Jaka, ADAPS, Enflame-Tech and Next Data.

The 2022 PEI 300 Global Private Equity Ranking was published on June 1st and CPE was selected as one of the Top 100 Private Equity Institutions with an international ranking of 57 and 5th in the Asia Pacific region. CPE continues to have a larger influence in Asia and across the world and its overall performance is increasingly recognized by international institutions.
 
The PEI 300 ranking is published by Private Equity International and evaluates the world's leading private equity institutions by fundraising volume over the past five years. Private Equity International was established in London in 2001 and it reports on issues and trends in the private equity industry, including funds, investors and industry moves. Its editorial and research teams are based in London, New York and Hong Kong. Private Equity International is globally recognized as a trusted media source focusing on issues related to investors and the wider private equity sector.

COM:CPE-FUND

Beijing Changrui Foundation

Analysis Not Available